Niessner, H.; Burkard, M.; Leischner, C.; Renner, O.; Plöger, S.; Meraz-Torres, F.; Böcker, M.; Hirn, C.; Lauer, U.M.; Venturelli, S.;
et al. Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In Vivo. Cells 2022, 11, 1229.
https://doi.org/10.3390/cells11071229
AMA Style
Niessner H, Burkard M, Leischner C, Renner O, Plöger S, Meraz-Torres F, Böcker M, Hirn C, Lauer UM, Venturelli S,
et al. Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In Vivo. Cells. 2022; 11(7):1229.
https://doi.org/10.3390/cells11071229
Chicago/Turabian Style
Niessner, Heike, Markus Burkard, Christian Leischner, Olga Renner, Sarah Plöger, Francisco Meraz-Torres, Matti Böcker, Constanze Hirn, Ulrich M. Lauer, Sascha Venturelli,
and et al. 2022. "Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In Vivo" Cells 11, no. 7: 1229.
https://doi.org/10.3390/cells11071229
APA Style
Niessner, H., Burkard, M., Leischner, C., Renner, O., Plöger, S., Meraz-Torres, F., Böcker, M., Hirn, C., Lauer, U. M., Venturelli, S., Busch, C., & Sinnberg, T.
(2022). Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In Vivo. Cells, 11(7), 1229.
https://doi.org/10.3390/cells11071229
